Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12042509 | Prekallikrein-modulating compositions and methods of use thereof | Zhen Li, Rui Zhu, Zhiqing (Joel) Zhou, Sean Studer | 2024-07-23 |
| 10004735 | Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines | Tam Minh Tran, Shuichan Xu, Weiming Xu | 2018-06-26 |
| 9737535 | Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines | Tam Minh Tran, Shuichan Xu, Weiming Xu | 2017-08-22 |
| 9557338 | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for tor kinase inhibitory activity | Weiming Xu, Deborah Mortensen, Shuichan Xu | 2017-01-31 |
| 9155736 | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity | Weiming Xu, Deborah Mortensen, Shuichan Xu | 2015-10-13 |
| 8507492 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more | 2013-08-13 |
| 8492381 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more | 2013-07-23 |
| 8110578 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more | 2012-02-07 |